newsfilter
← Latest News
Business Wire·

enGene Names Amy Pott as Chief Global Commercialization Officer

enGene Holdings Inc. (NASDAQ:ENGN), a clinical-stage, non-viral genetic medicines company, today announced the appointment of Amy Pott as Chief Global Commercialization Officer. In this role, Ms. Pott will serve as the